Carbon Nanomaterials for Targeted Cancer Therapy Drugs: A Critical Review
Language English Country United States Media print-electronic
Document type Journal Article, Review
Grant support
260/LPR/2018
The League Against Cancer Prague
PubMed
30156367
DOI
10.1002/tcr.201800038
Knihovny.cz E-resources
- Keywords
- Cancer, biomedical applications, carbon nanomaterials, nanomedicine, therapy,
- MeSH
- Quantum Dots chemistry MeSH
- Humans MeSH
- Neoplasms drug therapy therapy MeSH
- Drug Carriers chemistry MeSH
- Antineoplastic Agents therapeutic use MeSH
- Carbon chemistry MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Drug Carriers MeSH
- Antineoplastic Agents MeSH
- Carbon MeSH
Cancer represents one of the main causes of human death in developed countries. Most current therapies, unfortunately, carry a number of side effects, such as toxicity and damage to healthy cells, as well as the risk of resistance and recurrence. Therefore, cancer research is trying to develop therapeutic procedures with minimal negative consequences. The use of nanomaterial-based systems appears to be one of them. In recent years, great progress has been made in the field using nanomaterials with high potential in biomedical applications. Carbon nanomaterials, thanks to their unique physicochemical properties, are gaining more and more popularity in cancer therapy. They are valued especially for their ability to deliver drugs or small therapeutic molecules to these cells. Through surface functionalization, they can specifically target tumor tissues, increasing the therapeutic potential and significantly reducing the adverse effects of therapy. Their potential future use could, therefore, be as vehicles for drug delivery. This review presents the latest findings of research studies using carbon nanomaterials in the treatment of various types of cancer. To carry out this study, different databases such as Web of Science, PubMed, MEDLINE and Google Scholar were employed. The findings of research studies chosen from more than 2000 viewed scientific publications from the last 15 years were compared.
References provided by Crossref.org
Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer
